ARE Stock Overview
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 6/6 |
Rewards
Risk Analysis
Alexandria Real Estate Equities, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$104.31 |
52 Week High | US$135.45 |
52 Week Low | US$103.01 |
Beta | 1.18 |
11 Month Change | -12.73% |
3 Month Change | -11.87% |
1 Year Change | -0.27% |
33 Year Change | -50.42% |
5 Year Change | -35.73% |
Change since IPO | 396.71% |
Recent News & Updates
Alexandria Real Estate: Buy The Dip And Start The DRIP
Nov 16Alexandria Real Estate: Q3 Results Reinforce Bullish View
Oct 23Alexandria Real Estate: Recent Strategy Should Drive Its Stock Price Higher
Oct 16Recent updates
Alexandria Real Estate: Buy The Dip And Start The DRIP
Nov 16Alexandria Real Estate: Q3 Results Reinforce Bullish View
Oct 23Alexandria Real Estate: Recent Strategy Should Drive Its Stock Price Higher
Oct 16Alexandria Real Estate: Cheap But Still Growing, It Remains A Buy
Sep 07Alexandria Real Estate: Time To Buy This Mission-Critical REIT Now
Aug 07Alexandria Real Estate: Undervalued Passive Income Gem With A 4.2% Yield
Jul 15Alexandria: Buy This REIT Before The Valuation Reflects The Strong Business
Jul 05Alexandria Real Estate: Moat-Worthy Buy
Jun 25Alexandria Real Estate Equities Is Still Worth The Premium
May 31Alexandria Real Estate: This Quality Dividend Grower Is Still A Buy
May 25Alexandria Real Estate: Bargain-Buy Office REIT Deserving Of Another Look
Apr 23Alexandria Real Estate: Great Income Pick
Mar 22Alexandria Real Estate: The Time To Buy This Blue-Chip REIT Is Now
Feb 19Alexandria Real Estate: Ordinary After All
Feb 13Alexandria Real Estate: Wonderful Stock At A Wonderful Price
Jan 15Alexandria Real Estate: Last Call?
Dec 10Why I Believe 4%-Yielding Alexandria Real Estate Is The Best Office REIT On The Market
Dec 04Alexandria Real Estate: Life Sciences Demand Suggests Growth Potential
Nov 28Alexandria Real Estate's Fundamentals Keep Debunking The Doomsayers
Nov 02Alexandria Real Estate Q3 Earnings Preview: Expecting Continued Strength In Leasing And Occupancy
Oct 23Alexandria And Realty Income: My Current 2 Biggest 'Buys'
Sep 29Teleperformance And Alexandria Real Estate: 2 Companies With Potential Triple-Digit Upside
Sep 12Alexandria Real Estate: Why The Bears Are Wrong
Sep 06Alexandria Real Estate: 40% Discount And 4.3% Yield
Aug 25Alexandria Real Estate: Silly Rabbit, Shorting REITs Is For Kids
Aug 05Alexandria Real Estate: Q2 Results Distinguish It As An Undervalued Lab Operator
Jul 25Alexandria Real Estate Equities: The Market May Be Wrong About This 4.3% Yielding REIT
Jul 11Alexandria Real Estate: Rejecting The Office REIT Comparison
Jun 28Alexandria Real Estate Equities: Center Of A Real Estate Debate
Jun 22Alexandria Real Estate: The Market Has Got This Right
Jun 16Alexandria Real Estate Equities Q4 Earnings Preview
Jan 29Shareholder Returns
ARE | US Health Care REITs | US Market | |
---|---|---|---|
7D | -4.3% | 0.06% | -1.2% |
1Y | -0.3% | 36.4% | 30.4% |
Return vs Industry: ARE underperformed the US Health Care REITs industry which returned 36.4% over the past year.
Return vs Market: ARE underperformed the US Market which returned 30.4% over the past year.
Price Volatility
ARE volatility | |
---|---|
ARE Average Weekly Movement | 3.1% |
Health Care REITs Industry Average Movement | 3.1% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.5% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ARE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ARE's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 568 | Peter Moglia | www.are.com |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects.
Alexandria Real Estate Equities, Inc. Fundamentals Summary
ARE fundamental statistics | |
---|---|
Market cap | US$18.26b |
Earnings (TTM) | US$282.55m |
Revenue (TTM) | US$3.09b |
64.5x
P/E Ratio5.9x
P/S RatioIs ARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ARE income statement (TTM) | |
---|---|
Revenue | US$3.09b |
Cost of Revenue | US$891.56m |
Gross Profit | US$2.19b |
Other Expenses | US$1.91b |
Earnings | US$282.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.62 |
Gross Margin | 71.10% |
Net Profit Margin | 9.16% |
Debt/Equity Ratio | 55.9% |
How did ARE perform over the long term?
See historical performance and comparison